LTR Pharma has announced the expansion of patient access to its erectile dysfunction treatment, Spontan, via a nationwide rollout through pharmacies dispensing under the TGA's Special Access Scheme and Authorised Prescriber Scheme.
The fast-acting intranasal alternative to traditional oral PDE5 inhibitors comes in commercial packaging, including a TGA-compliant barcode.
Dispensing is supported by trained pharmacists and enhances physical access for patients with prescriptions from authorised healthcare professionals.
It will be available at over 600 pharmacies across Australia, distributing via the TerryWhite Chemmart network, Pharmacy Choice and healthSAVE.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 May 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 May 25
